July 28, 2022
Related Materials: Latest CDC Monkeypox Health Alert (cdc.gov) | Latest California Monkeypox Health Alert | CDC Health Alert Network (HAN) | California Health Alert Network (CAHAN)
Latest News Releases: State of Emergency (gov.ca.gov) | State Provides Update on Monkeypox Response on July 29
The current monkeypox situation is rapidly evolving and the information below will be updated as new information emerges. CDPH is closely monitoring monkeypox transmission in the U.S. and California to ensure rapid identification of cases. The risk of monkeypox to the public is currently very low based on the information available. While monkeypox can infect anyone, many of the recent cases in 2022 have occurred among persons self-identifying as men who have sex with men (MSM).
Monkeypox in California
Data as of July 28, 2022
Number of reported probable and confirmed monkeypox cases in California
āGay, Lesbian or same gender loving
| ā508
| ā91.7
|
āBisexual
| ā31
| ā5.6
|
āHeterosexual or straight
| ā11
| ā2.0
|
āOther
| ā4
| ā0.7
|
āMissing/Unknown
| ā232
| ā-
|
ā* Among cases with available data
** includes groups with small numbers of reported cases

About Monkeypox
Monkeypox is a rare disease that is caused by infection with the monkeypox virus. Monkeypox virus belongs to the Orthopoxvirus genus which includes the variola (smallpox) virus as well as the vaccinia virus, which is used in the smallpox vaccine. Monkeypox is of public health concern because the illness is similar to smallpox and can be spread from infected humans, animals, and materials contaminated with the virus. Monkeypox is less transmissible and usually less severe than smallpox.
Monkeypox was first identified in 1958 and occurs primarily in Central and West African countries. Historically, monkeypox cases have rarely occurred in the U.S. and had mostly been related to international travel or importation of animals. There is a recent significant increase in reported cases where monkeypox is not commonly seen, including in Europe, Canada, the United States and California. While it's good to stay alert about any emerging public health outbreaks, the current risk of getting monkeypox in the general public is very low.
Symptoms
Monkeypox might start with symptoms like the flu, with fever, low energy, swollen lymph nodes, and general body aches. Within 1 to 3 days (sometimes longer) after the appearance of fever, the person can develop a rash or sores. The sores will go through several stages, including scabs, before healing. They can look like pimples or blisters and may be painful and itchy.
The rash or sores may be located on or near the genitals (penis, testicles, labia, and vagina) or anus (butt) but could also be on other areas like the hands, feet, chest, and face. They may also be limited to one part of the body.
People with monkeypox may experience all or only a few of these symptoms. Most with monkeypox will develop the rash or sores. Some people have reported developing a rash or sores before (or without) the flu-like symptoms. Monkeypox can spread from the time symptoms start until all sores have healed and a fresh layer of skin has formed. This can take several weeks.
Transmission
Monkeypox spreads primarily through direct contact with infectious sores, scabs, or body fluids, including during sex, as well as activities like kissing, hugging, massaging, and cuddling. Monkeypox can spread through touching materials used by a person with monkeypox that havenāt been cleaned, such as clothing and bedding. It can also spread by respiratory secretions during prolonged, close, face-to-face contact.
Prevention
There are number of ways to prevent the spread of monkeypox, including:
Always talking to your sexual partner/s about any recent illness and being aware of new or unexplained sores or rashes on your body or your partnerās body, including on the genitals and anus
Avoiding close contact, including sex, with people with symptoms like sores or rashes
Practicing good hand hygiene
People who become infected should isolate until their symptoms are improving or have gone away completely. Rash should always be well covered until completely healed.
Using appropriate personal protective equipment (PPE) (like a mask, gown, and gloves) when caring for others with symptoms
Avoiding contact with infected materials contaminated with the virus
Avoiding contact with infected animals
Diagnoses
If you have a new or an unexplained rash or other symptoms, seek medical care for further testing and evaluation.
Wear a mask and tell your healthcare provider of your current symptoms for possible monkeypox.
If you do not have a healthcare provider or healthcare insurance, visit a public health clinic or local county clinic.
Avoid crowds, close contact, including sexual or intimate contact until seeing your healthcare provider.
Vaccination
Vaccination helps to protect against monkeypox when given before or shortly after an exposure. JYNNEOS and ACAM2000 are two monkeypox vaccines currently available in the United States via the Strategic National Stockpile.
At this time, the federal government has allocated a limited number of JYNNEOS vaccine doses to Californians. CDPH is working with local health departments to make these doses available to protect against monkeypox. JYNNEOS is licensed for adults 18 years and over. It is administered as a two dose injection series in the upper arm at least four weeks apart. Most people who receive the JYNNEOS vaccine have only minor reactions such as pain, redness, swelling and itching at the injection site. Less commonly, people also may experience muscle pain, headache, fatigue (tiredness), nausea, chills, and fever.
The CDC advises that people who have been exposed to monkeypox be given the vaccine to prevent them from developing the disease. This is called post-exposure prophylaxis or PEP. PEP is most effective at preventing monkeypox if the vaccine is administered within 4 days of exposure. If given between 4ā14 days after the date of exposure, vaccination may help reduce symptoms, but may not prevent the infection from developing.
At this time, the JYNNEOS vaccine is being prioritized for the following groups:
Post-Exposure Prophylaxis (PEP) for known close contacts of monkeypox cases who are identified by public health via case investigation, contact tracing, and risk exposure assessments.
Post-Exposure Prophylaxis (PEP)++ for individuals with certain risk factors who are more likely to have been recently exposed to monkeypox even if they have not had documented exposure to someone with confirmed monkeypox, such as people who attended an event or venue where there was known monkeypox exposure.
Pre-Exposure Prophylaxis (PrEP) for individuals at occupational risk of monkeypox according to Advisory Committee on Immunization Practices (ACIP) guidance, including: laboratory workers who perform monkeypox testing, and clinical and public health workers who collect monkeypox specimens.
On July 19,
California sent a letter to the Centers for Disease
Control and Prevention outlining a request for additional doses of vaccine. Additional doses will eventually allow for expansion of vaccination efforts to include PrEP to other individuals, including gay, bisexual, trans and other men who have sex with men who are at high risk of monkeypox exposure.
For healthcare providers, additional monkeypox vaccine information can be found at EZIZ Monkeypox Vaccination Resources.